Skip to main content
Joseph Antin

Oncology

Joseph Antin, MD

Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus

Boston, MA

Dr. Joseph Antin is a hematology and medical oncology specialist at Dana-Farber Cancer Institute specializing in Aplastic anemia, Bone marrow failure, Graft-versus-host disease and Graft-versus-leukemia, Paroxysmal nocturnal hemoglobinuria (PNH), Stem cell/bone marrow transplantation, serving as Chairman of the Steering Committee of the BMT Clinical Trial Network.; Chief, Stem Cell Transplantation, Emeritus.

45+

Years in Practice

Credentials

Board Certifications

  • Hematology, 1984
  • Internal Medicine, 1981
  • Medical Oncology, 1983

Education & Training

  • Weill Medical College of Cornell University (MD)
  • Brigham and Women's Hospital, Hematology (Fellowship)
  • Dana-Farber Cancer Institute, Oncology (Fellowship)

Peer Recognition

  • Castle ConnollyTop Doctor

    2002-2026 (25 years)

Clinical Focus

Subspecialties

Medical Oncology

Conditions & Treatments

Stem Cell TransplantLeukemiaClinical Trials & Drug Development

Practice Details

Hospital Affiliations

  • Dana-Farber Cancer Institute

Experience

45+ years in practice